Emerging Targets in Type 2 Diabetes and Diabetic Complications
Abstract Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects. More importantly, once diagnosed dia...
Main Authors: | Sevgican Demir, Peter P. Nawroth, Stephan Herzig, Bilgen Ekim Üstünel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-09-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202100275 |
Similar Items
-
JAK-STAT signaling pathway and diabetic complications
by: YU Ziman, ZHAO Bingjia, YANG Dan
Published: (2023-10-01) -
N6-methyladenosine RNA modification: an emerging molecule in type 2 diabetes metabolism
by: Haocheng Zhang, et al.
Published: (2023-07-01) -
Type 2 Diabetes Complicated With Heart Failure: Research on Therapeutic Mechanism and Potential Drug Development Based on Insulin Signaling Pathway
by: Hui Ye, et al.
Published: (2022-03-01) -
Diabetic Pneumopathy–A New Diabetes-Associated Complication: Mechanisms, Consequences and Treatment Considerations
by: Stefan Kopf, et al.
Published: (2021-11-01) -
Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications
by: Sravya Jannapureddy, et al.
Published: (2021-03-01)